<![CDATA[Samsung Epis Holdings Co., Ltd. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=49375>Mon, 04 May 2026 11:22:15 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results]]>https://www.newswire.co.kr/newsRead.php?no=1027588Mon, 26 Jan 2026 16:11:50 +0900<![CDATA[Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference]]>https://www.newswire.co.kr/newsRead.php?no=1026976Thu, 15 Jan 2026 10:03:19 +0900<![CDATA[Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms]]>https://www.newswire.co.kr/newsRead.php?no=1022744Tue, 11 Nov 2025 16:20:00 +0900<![CDATA[Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary]]>https://www.newswire.co.kr/newsRead.php?no=1022029Mon, 03 Nov 2025 11:44:35 +0900